首页> 外文学位 >A cellular immune response marker: Neopterin and its potential applications.
【24h】

A cellular immune response marker: Neopterin and its potential applications.

机译:细胞免疫应答标记物:新蝶呤及其潜在应用。

获取原文
获取原文并翻译 | 示例

摘要

Neopterin measurement can be a very useful screening test when there is an outbreak of newly emerging infectious disease. Serum neopterin concentrations were elevated in patients suffering from severe acute respiratory syndrome and dengue fever as early as on the first day of the onset of symptoms.;Neopterin can also act as a gate-keeper in blood transfusion process to improve blood safety. A total of 3756 volunteer donors from Guangzhou Blood Transfusion centre were tested with neopterin. The upper reference levels were set as 11.5 nmol/L (95th percentile) and 14.7 nmol/L (98 th percentile), which were higher than the upper reference level (10 nmol/L, 98th percentile) set in Europe.;Neopterin measurement in the combination with other biomarkers is a very useful tool to differentiate viral infection from bacterial infection. The area under the receiver operating characteristic curve was the highest if the markers were used in combination. By using the C-reaction protein to neopterin (C/N) ratio, an optial cutoff at C/N ratio > 3 gave a sensitivity of 85% and a specificity of 82%.;InfectCheck NEO rapid test, a point of care test, for semi-quantitative detection of neopterin, has been successfully developed. The test result is available in 15 minutes. The analytic performance of the test was compared with a commercial neopterin ELISA and in a substantial agreement (kappa = 0.67). The intra-assay and inter-assay variations were within 20%. The InfectCheck NEO rapid test is stable at either 4°C or room temperature for up to 1 year without any significant loss of activity. It does not require any special expertise to perform the test nor specialized laboratory setting or expensive reading devices. It can act as an efficient gate-keeper at the triages of hosptials, clinics and blood transfusion centers to exclude viral infected patients.
机译:当新出现的传染病爆发时,新蝶呤的测量可能是非常有用的筛选测试。患有严重急性呼吸系统综合症和登革热的患者最早在症状发作的第一天就升高了血清新蝶呤的浓度。新蝶呤还可以在输血过程中起到守门人的作用,以提高血液安全性。用新蝶呤对来自广州输血中心的3756名志愿者捐赠者进行了测试。最高参考水平设定为11.5 nmol / L(第95个百分位数)和14.7 nmol / L(98个百分点),高于欧洲设定的最高参考水平(10 nmol / L,第98个百分点)。与其他生物标记物组合使用时,是区分病毒感染和细菌感染的非常有用的工具。如果组合使用标记,则接收器工作特性曲线下的面积最高。通过使用C反应蛋白与新蝶呤(C / N)的比率,在C / N比率> 3时的视阈值可得出85%的敏感性和82%的特异性。; InfectCheck NEO快速测试,即时护理用于新蝶呤的半定量检测的,已经成功开发。测试结果可在15分钟内获得。该测试的分析性能与商业新蝶呤ELISA进行了比较,并且基本一致(kappa = 0.67)。批内和批间差异在20%以内。 InfectCheck NEO快速测试可在4°C或室温下稳定长达1年,而没有任何明显的活性损失。它不需要任何专业知识即可执行测试,也不需要专门的实验室设置或昂贵的读取设备。它可以在医院,诊所和输血中心分流中充当有效的看门人,以排除病毒感染的患者。

著录项

  • 作者

    Leung, Man Fai.;

  • 作者单位

    Hong Kong University of Science and Technology (Hong Kong).;

  • 授予单位 Hong Kong University of Science and Technology (Hong Kong).;
  • 学科 Chemistry Analytical.;Health Sciences Immunology.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 164 p.
  • 总页数 164
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号